de Glas Nienke A, de Craen Anton J M, Bastiaannet Esther, Op 't Land Ester G, Kiderlen Mandy, van de Water Willemien, Siesling Sabine, Portielje Johanneke E A, Schuttevaer Herman M, de Bock Geertruida Truuske H, van de Velde Cornelis J H, Liefers Gerrit-Jan
Department of Surgery, Leiden University Medical Centre, PO Box 9600, Postzone K6-R, 2300 RC, Leiden, Netherlands Department of Gerontology and Geriatrics, Leiden University Medical Centre, Leiden, Netherlands.
Department of Gerontology and Geriatrics, Leiden University Medical Centre, Leiden, Netherlands.
BMJ. 2014 Sep 14;349:g5410. doi: 10.1136/bmj.g5410.
To assess the incidence of early stage and advanced stage breast cancer before and after the implementation of mass screening in women aged 70-75 years in the Netherlands in 1998.
Prospective nationwide population based study.
National cancer registry, the Netherlands.
Patients aged 70-75 years with a diagnosis of invasive or ductal carcinoma in situ breast cancer between 1995 and 2011 (n=25,414). Incidence rates were calculated using population data from Statistics Netherlands.
Incidence rates of early stage (I, II, or ductal carcinoma in situ) and advanced stage (III and IV) breast cancer before and after implementation of screening. Hypotheses were formulated before data collection.
The incidence of early stage tumours significantly increased after the extension for implementation of screening (248.7 cases per 100,000 women before screening up to 362.9 cases per 100,000 women after implementation of screening, incidence rate ratio 1.46, 95% confidence interval 1.40 to 1.52, P<0.001). However, the incidence of advanced stage breast cancers decreased to a far lesser extent (58.6 cases per 100,000 women before screening to 51.8 cases per 100,000 women after implementation of screening, incidence rate ratio 0.88, 0.81 to 0.97, P<0.001).
The extension of the upper age limit to 75 years has only led to a small decrease in incidence of advanced stage breast cancer, while that of early stage tumours has strongly increased.
评估1998年荷兰对70 - 75岁女性实施大规模筛查前后早期和晚期乳腺癌的发病率。
前瞻性全国性基于人群的研究。
荷兰国家癌症登记处。
1995年至2011年间诊断为浸润性或导管原位癌的70 - 75岁患者(n = 25414)。发病率使用荷兰统计局的人口数据计算。
筛查实施前后早期(I、II期或导管原位癌)和晚期(III期和IV期)乳腺癌的发病率。在数据收集前制定假设。
筛查实施范围扩大后,早期肿瘤的发病率显著增加(筛查前每10万名女性中有248.7例,实施筛查后每10万名女性中有362.9例,发病率比值为1.46,95%置信区间为1.40至1.52,P < 0.001)。然而,晚期乳腺癌的发病率下降幅度要小得多(筛查前每10万名女性中有58.6例,实施筛查后每10万名女性中有51.8例,发病率比值为0.88,0.81至0.97,P < 0.001)。
将年龄上限延长至75岁仅导致晚期乳腺癌发病率略有下降,而早期肿瘤的发病率则大幅上升。